PRINCETON, N.J., Oct. 3, 2012 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today the formation of a Scientific Advisory Board (SAB) to provide strategic guidance to the Company as it relates to the...
ALBANY, New York, October 3, 2012 /PRNewswire/ -- New Report Added in ResearchMoz Reports Database Clinical Supply Chain Management - Technologies such as IVRS, CTMS, EDC and RFID Enhance Drug Supply Management GBI Research, leading business intelligence provider has released its...
AMES, Iowa, Oct. 3, 2012 /PRNewswire/ -- NewLink Genetics Corporation (Nasdaq: NLNK) announces the launching of an open-label, randomized, multi-institutional adaptive design Phase2B/3 study to evaluate efficacy of its tergenpumatucel-L (HyperAcute® Lung) product candidate in patients with progressive or relapsed Stage-IIIB/IV...
FRANKLIN LAKES, N.J., Oct. 3, 2012 /PRNewswire/ -- BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA)...
CINCINNATI, Oct. 3, 2012 /PRNewswire-USNewswire/ -- The Academy of Managed Care Pharmacy (AMCP) today opened its 2012 Educational Conference in Cincinnati, Ohio. The event brings together approximately two thousand pharmacists and other health care professionals who develop and administer pharmacy benefits...
LONDON, Oct. 3, 2012 /PRNewswire/ -- Smith & Nephew (LSE: SN, NYSE: SNN), the global medical technology business today announces the launch of the TRIGEN™ Low-Profile Screw – the only truly "captured" head, low-profile screw on the market. Patented by...
HONG KONG, Oct. 3, 2012 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), the first and largest cord blood banking operator in China, announced that it has successfully completed the previously announced $50 million convertible...
MENLO PARK, Calif., Oct. 3, 2012 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) announced today that it is presenting two abstracts from its Phase 3 clinical trial, BREEZE 3, at this week's 23rd Annual Meeting of the North American Menopause Society...
REDWOOD CITY, Calif., Oct. 3, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced the addition of three industry veterans to its senior leadership team. Dr. Vance Vanier joins Verinata as President,...
SAN FRANCISCO, Oct. 3, 2012 /PRNewswire/ -- Ozone, a leading integrated digital marketing agency, has been named a finalist for an award by Medical Marketing and Media. The MM&M Awards annually recognize creativity and marketing effectiveness in health care. Following two...
